about
Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study)Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failureHeart failure prognosis and management in over-80-year-old patients: data from a French national observational retrospective cohort.Signs and symptoms in chronic heart failure: relevance of clinical trial results to point of care-data from Val-HeFT.Do we have reasons to be enthusiastic about pacing to treat advanced heart failure?Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification.Survival of patients with a new diagnosis of heart failure: a population based studyMode of death in heart failure: findings from the ATLAS trialAssociation of impedance cardiography parameters with changes in functional and quality-of-life measures in patients with chronic heart failure.Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction.A history of arterial hypertension does not affect mortality in patients hospitalised with congestive heart failureRole of echocardiography in the contemporary management of chronic heart failure.Lower body mass index and atrial fibrillation as independent predictors for mortality in patients with implantable cardioverter defibrillator.Risk stratification in heart failure using artificial neural networks.Depression and Multiple Rehospitalizations in Patients With Heart Failure.Comparison of the beneficial effect of beta-blockers on mortality in patients with ischaemic or non-ischaemic systolic heart failure: a meta-analysis of randomised controlled trials.Prognostic value of systolic short-term blood pressure variability in systolic heart failurePredictors of early mortality in implantable cardioverter-defibrillator recipients.Visually estimated ejection fraction by two dimensional and triplane echocardiography is closely correlated with quantitative ejection fraction by real-time three dimensional echocardiographyCardiac resynchronization therapy: redefining the role of device therapy in heart failure.Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndromeHow to assess new treatments for the management of heart failure: composite scoring systems to assess the patients' clinical journey.Functional Impact of Ryanodine Receptor Oxidation on Intracellular Calcium Regulation in the Heart.Major Depression and Long-Term Survival of Patients With Heart Failure.Clinical Effect of Cardiac Shock Wave Therapy on Myocardial Ischemia in Patients With Ischemic Heart Failure.Impact of clinical characteristics and management on the prognosis of unselected heart failure patients.Estimating prognosis in heart failure: time for a better approach.Predictors of unfavourable prognosis in chronic Chagas' disease.NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy.Cardiac resynchronization therapy: an option for inotrope-supported patients with end-stage heart failure?Assessment of left ventricular size and function during cardiac surgery. An intraoperative evaluation of six two-dimensional echocardiographic methods with real time three-dimensional echocardiography as a reference.Short to long term mortality of patients hospitalised with heart failure in the Czech Republic--a report from the EuroHeart Failure Survey.Predicting functional capacity in patients with a systemic right ventricle: subjective patient self-assessment is better than B-type natriuretic peptide levels and right ventricular systolic function.Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology.Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure.Determinants of maximal exercise performance in chronic heart failure.Image quality influences the assessment of left ventricular function: an intraoperative comparison of five 2-dimensional echocardiographic methods with real-time 3-dimensional echocardiography as a reference.Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL.Effect of a heart failure clinic on survival and hospital readmission in patients discharged from acute hospital care.Validation of an echocardiographic wall motion index in heart failure due to ischaemic heart disease.
P2860
Q28194101-050506E1-57B7-4670-A541-9D582B66E5DDQ30478728-24905339-CD31-4398-8615-EE51A73D943BQ30881762-1EB315DD-CB57-4405-91AE-95811C031D0EQ31028056-56AEEA44-304A-420F-9D51-1B91218AAF23Q33997992-B530A5EB-CEB6-4BA8-BD32-855F6F46B8B0Q35374859-18FB50D0-CFD2-4766-8E16-09F79300DFFAQ35566720-4E27EABD-ECF8-4E40-8F77-ACB067AD3A91Q35580685-FAE0BE47-6D27-40E5-A3AB-F0F0802E82EDQ35741773-96CAF6A8-B27A-4411-94C2-0B1EEEB1EE2FQ35770870-7B3EE1E0-8899-450D-ABE4-8812A57A2D46Q35771978-2ED4081C-B937-42CF-9D64-9F9DEC4E5FEDQ36050476-ECE80651-EAD2-4C5A-BFAC-5ADB6AC038CAQ36147999-04BB1FDA-86CC-44DE-8565-6792E2B5F1CFQ36461273-5A0A57DF-C6FD-48ED-B947-4A247A1F61D9Q36932609-077FB32B-FF51-407A-9624-BB97E95D9742Q36970941-2E958012-57B0-4B32-8F9C-D42808A4D036Q37090096-C8B366B3-BC17-4DC3-9F84-A2B8953D864AQ37202195-8E78ADC5-C910-46E7-A392-80E0ED9E406FQ37355737-9E2B9291-B5E0-491D-8210-897E2EFA1930Q37763167-3FEB6333-25FF-4937-9C8B-781F11CFDFA2Q37831838-E2F00CE8-8886-41FC-A431-CEBD8B64884CQ38576972-A9EA63B3-3FF1-4D50-9F79-F4F975159268Q38850764-AC709D1E-7BC5-4204-A07A-D075397E4BCDQ39760017-6CEA7C13-C089-4481-9AC9-40254AB6141AQ40221365-A7E6FF7E-8455-4FB6-B459-732B36E44724Q41381001-7981C6C7-0C51-4A1B-B830-490DDF399723Q43014760-1966BCC1-395A-4311-A69D-903E107FA85CQ43871653-15017AE5-FD7E-48BE-887D-1DB431932DA8Q44778772-F2EC6BF2-1692-4158-8116-930B5F7C6D5AQ45257978-DBDCC227-F5DC-471E-A7C1-0443975182B1Q46503562-98F092DD-F6D1-4020-9DEF-D645A821E2E1Q46624370-DEA0A8D6-AAFB-4E46-9D13-A26D4AB59CE5Q46872176-6B2252C4-F213-4529-BF2E-3FB53FE12665Q47660867-EA8F37E7-FEEE-45CB-8548-0798F5C266D6Q49161329-BC4D29BB-842E-4009-8799-66C7884892A0Q49192277-AF4194A6-8902-407C-BC0B-7F05787F401CQ50624222-7F5C2334-CD5F-4E5D-BD1A-F6977C9347C0Q50696171-5F71C609-4B7C-40F5-91F4-2271DE265DA6Q52039710-704B9D3E-F218-4634-A731-B6C788AD0179Q52936095-8A517F62-D442-4B36-AC83-BEDF2195C783
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Risk stratification in chronic heart failure.
@en
Risk stratification in chronic heart failure.
@nl
type
label
Risk stratification in chronic heart failure.
@en
Risk stratification in chronic heart failure.
@nl
prefLabel
Risk stratification in chronic heart failure.
@en
Risk stratification in chronic heart failure.
@nl
P356
P1476
Risk stratification in chronic heart failure
@en
P2093
P J Cowburn
P304
P356
10.1053/EUHJ.1997.0820
P577
1998-05-01T00:00:00Z